Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on February 9, 2015. The filing serves as a Regulation FD disclosure regarding a presentation made by a company representative at the 17th annual BIO CEO & Investor Conference held in New York, NY.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a conference presentation and does not contain a financial statement or earnings data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely discloses the occurrence of the conference presentation and the availability of the presentation slides.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in the report and the attached exhibit (conference slides) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities of that section nor incorporated by reference into other filings, except as expressly set forth by specific reference. The filing does not provide specific management commentary, guidance, or risk factors within the text of the 8-K itself.
Investor Verification Checklist
- Verify the company name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review the attached Exhibit 99.01 (conference slides) for any specific operational updates or forward-looking statements, as the 8-K text itself contains no such details.
- Confirm that the conference presentation slides are available on the company website (www.neuralstem.com) as referenced in the filing.
- Note that the information in this 8-K is not considered "filed" under Section 18 of the Exchange Act.